277 related articles for article (PubMed ID: 10957805)
1. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
Amelin AV; Skoromets AA; Ignatov IuD
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
[No Abstract] [Full Text] [Related]
2. Serotonin in migraine: theories, animal models and emerging therapies.
Johnson KW; Phebus LA; Cohen ML
Prog Drug Res; 1998; 51():219-44. PubMed ID: 9949863
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1F receptor agonists in acute migraine treatment: a hypothesis.
Ramadan NM; Skljarevski V; Phebus LA; Johnson KW
Cephalalgia; 2003 Oct; 23(8):776-85. PubMed ID: 14510923
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic advances in migraine.
Solomon GD
J Clin Pharmacol; 1993 Mar; 33(3):200-9. PubMed ID: 8385160
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
Pranzatelli MR
Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxytryptamine (5-HT) receptor ligands.
Kitson SL
Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
[TBL] [Abstract][Full Text] [Related]
7. Targeting 5-HT receptors for the treatment of obesity.
Sargent BJ; Henderson AJ
Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
[TBL] [Abstract][Full Text] [Related]
8. On serotonin and migraine: a clinical and pharmacological review.
Ferrari MD; Saxena PR
Cephalalgia; 1993 Jun; 13(3):151-65. PubMed ID: 8395342
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
10. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
[No Abstract] [Full Text] [Related]
11. 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?
Neeb L; Meents J; Reuter U
Neurotherapeutics; 2010 Apr; 7(2):176-82. PubMed ID: 20430316
[TBL] [Abstract][Full Text] [Related]
12. Preface. Physiological, pathophysiological and therapeutic aspects of 5-HT mechanisms.
Meneses A
Behav Brain Res; 2008 Dec; 195(1):1. PubMed ID: 18706936
[No Abstract] [Full Text] [Related]
13. Clinical pharmacology of migraine.
Bousser MG
Pathol Biol (Paris); 1992 Apr; 40(4):269-72. PubMed ID: 1495809
[No Abstract] [Full Text] [Related]
14. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
15. [Migraine, serotonin and serotonergic receptors].
Pascual J
Neurologia; 1993; 8(6):180-3. PubMed ID: 8394726
[No Abstract] [Full Text] [Related]
16. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
Dlohozková N; Metys J; Valchár M; Soucek R
Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
[No Abstract] [Full Text] [Related]
17. Serotonin-active drugs.
Rosenberg MD; Strassels SA
J Mass Dent Soc; 2000; 48(4):48-50. PubMed ID: 11819931
[No Abstract] [Full Text] [Related]
18. New drugs for migraine.
Stovner LJ; Tronvik E; Hagen K
J Headache Pain; 2009 Dec; 10(6):395-406. PubMed ID: 19795182
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute migraine.
Miller FG
Lancet; 2002 Mar; 359(9308):802. PubMed ID: 11888631
[No Abstract] [Full Text] [Related]
20. 5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks.
Olesen J
Cephalalgia; 2010 Oct; 30(10):1157-8. PubMed ID: 20855360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
